Kupando
PrivateLast Round
Series A
Extension
Mar 18, 2026
Total Funding Raised
$24.09M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kupando operates in Consumer & Commerce and is based in Schönefeld. Its latest recorded funding round was a Series A Extension round in March 2026.
Kupando is a biopharmaceutical company developing small-molecule immunotherapies that stimulate the innate immune system to address unmet needs in oncology and infectious diseases.
Sector
Consumer & Commerce
Verticals
E-commerce, Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kupando Comparables
Compare Kupando with similar companies based on industry and business-model similarity.
No comparables are published for Kupando. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
Kupando Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 18, 2026 | ||||
| Series A | Sep 26, 2022 |
For institutional investors. Book with your work email.
Kupando Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investitionsbank des Landes Brandenburg | Series A Extension |
| LifeCare Partners | Series A Extension, Series A |
| Remiges Ventures | Series A Extension, Series A |
| Brandenburg Kapital | Series A Extension, Series A |
| Ventura BioMed Investors | Series A Extension, Series A |
| CARMA FUND | Series A Extension |
| High-Tech Gründerfonds | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
$11.5M raised in Series A Extension round.
- Sep 26, 2022
$13M round led by LifeCare Partners and Remiges Ventures.
For institutional investors. Book with your work email.
Kupando Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kupando's valuation, stock price, and market status.
Is Kupando a public or private company?
Kupando is a private company.
What is the current stock price of Kupando?
Kupando is a private company, so its shares have no public market price. Caplight tracks Kupando's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kupando worth (valuation)?
Valuation information for Kupando is not publicly available.
Can I buy Kupando stock?
Kupando shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kupando's last funding round?
Kupando's most recent funding round was Series A Extension on March 18, 2026.
Who are the main investors in Kupando?
Key investors in Kupando include LifeCare Partners, Remiges Ventures.
Will Kupando IPO soon?
No public IPO plans have been announced for Kupando.
How can I track Kupando secondary market activity?
Caplight tracks bids, offers, and trades in Kupando's shares on secondary markets.